To develop prognostic models integrating delta radiomics from prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) and dosiomics with clinical variables to predict metastasis-free survival (MFS) in patients with lo...
Ozan Cem Guler, MDBirhan Demirhan, MDAysenur Elmali, MDCem Onal, MD
Therapy Physics